| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.
|
JAMA
|
2001
|
24.12
|
|
2
|
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.
|
Stroke
|
1991
|
22.23
|
|
3
|
Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.
|
Circulation
|
1998
|
19.93
|
|
4
|
A comparison of rate control and rhythm control in patients with atrial fibrillation.
|
N Engl J Med
|
2002
|
16.31
|
|
5
|
Rhythm control versus rate control for atrial fibrillation and heart failure.
|
N Engl J Med
|
2008
|
6.17
|
|
6
|
Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study.
|
Circulation
|
1994
|
4.52
|
|
7
|
ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: full text: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 guidelines for the management of patients with atrial fibrillation) developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.
|
Europace
|
2006
|
3.52
|
|
8
|
Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial.
|
Lancet
|
2000
|
3.36
|
|
9
|
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society.
|
Circulation
|
2014
|
3.28
|
|
10
|
Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study.
|
J Am Coll Cardiol
|
2003
|
2.73
|
|
11
|
Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone. A randomized, placebo-controlled study.
|
Eur Heart J
|
1999
|
2.21
|
|
12
|
Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation.
|
Europace
|
2011
|
1.93
|
|
13
|
Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of a randomized, controlled study.
|
J Am Coll Cardiol
|
1996
|
1.83
|
|
14
|
Likelihood of spontaneous conversion of atrial fibrillation to sinus rhythm.
|
J Am Coll Cardiol
|
1998
|
1.68
|
|
15
|
Management of atrial fibrillation: review of the evidence for the role of pharmacologic therapy, electrical cardioversion, and echocardiography.
|
Ann Intern Med
|
2003
|
1.65
|
|
16
|
A prospective, randomized trial of an emergency department observation unit for acute onset atrial fibrillation.
|
Ann Emerg Med
|
2008
|
1.56
|
|
17
|
A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.
|
Ann Emerg Med
|
2000
|
1.55
|
|
18
|
Rapid loading of sotalol or amiodarone for management of recent onset symptomatic atrial fibrillation: a randomized, digoxin-controlled trial.
|
Am Heart J
|
2004
|
1.55
|
|
19
|
Amiodarone as a first-choice drug for restoring sinus rhythm in patients with atrial fibrillation: a randomized, controlled study.
|
Chest
|
2000
|
1.45
|
|
20
|
Conversion of recent-onset atrial fibrillation with intravenous amiodarone: a meta-analysis of randomized controlled trials.
|
Pharmacotherapy
|
2002
|
1.42
|
|
21
|
Efficacy and safety of intravenous amiodarone in recent-onset atrial fibrillation: experience in patients admitted to a general internal medicine department.
|
Postgrad Med J
|
1999
|
1.39
|
|
22
|
Management of newly detected atrial fibrillation: a clinical practice guideline from the American Academy of Family Physicians and the American College of Physicians.
|
Ann Intern Med
|
2003
|
1.33
|
|
23
|
Rhythm vs. rate control of atrial fibrillation meta-analysed by number needed to treat.
|
Br J Clin Pharmacol
|
2005
|
1.03
|
|
24
|
Analysis of current management of atrial fibrillation in the acute setting: GEFAUR-1 study.
|
Ann Emerg Med
|
2005
|
1.01
|
|
25
|
Risk of initiating antiarrhythmic drug therapy for atrial fibrillation in patients admitted to a university hospital.
|
Ann Intern Med
|
1997
|
0.97
|
|
26
|
Comparison of intravenous flecainide, propafenone, and amiodarone for conversion of acute atrial fibrillation to sinus rhythm.
|
Am J Cardiol
|
2000
|
0.94
|
|
27
|
Clinical implications of left atrial enlargement: a review.
|
Ochsner J
|
2009
|
0.91
|
|
28
|
Amiodarone for pharmacological cardioversion of recent-onset atrial fibrillation.
|
Int J Cardiol
|
2003
|
0.90
|
|
29
|
The RACE study in perspective of randomized studies on management of persistent atrial fibrillation.
|
Card Electrophysiol Rev
|
2003
|
0.89
|
|
30
|
Amiodarone versus placebo and class Ic drugs for cardioversion of recent-onset atrial fibrillation: a meta-analysis.
|
J Am Coll Cardiol
|
2003
|
0.87
|
|
31
|
Management of atrial fibrillation: the need for AFFIRMative action. AFFIRM investigators. Atrial Fibrillation Follow-up Investigation of Rhythm Management.
|
Am J Cardiol
|
1999
|
0.84
|
|
32
|
Clinical review: clinical management of atrial fibrillation - rate control versus rhythm control.
|
Crit Care
|
2004
|
0.82
|
|
33
|
Ibutilide versus amiodarone in atrial fibrillation: a double-blinded, randomized study.
|
Crit Care Med
|
2003
|
0.80
|
|
34
|
A comparative study of the efficacy and safety of procainamide versus propafenone versus amiodarone for the conversion of recent-onset atrial fibrillation.
|
Am J Cardiol
|
2007
|
0.80
|
|
35
|
Single high oral dose amiodarone for cardioversion of recent onset atrial fibrillation.
|
Heart Lung Circ
|
2012
|
0.78
|
|
36
|
Intravenous amiodarone for cardioversion of recent-onset atrial fibrillation.
|
Clin Cardiol
|
2003
|
0.76
|
|
37
|
Early recurrence of arrhythmia in patients taking amiodarone or class 1C agents for treatment of atrial fibrillation or atrial flutter.
|
Am J Cardiol
|
2004
|
0.76
|
|
38
|
Amiodarone infusion in the treatment of acute atrial fibrillation or flutter: high versus low dose treatment.
|
Heart
|
2005
|
0.75
|
|
39
|
Intravenous and oral administration of amiodarone for the treatment of recent onset atrial fibrillation after digoxin administration.
|
Int J Cardiol
|
2007
|
0.75
|
|
40
|
The role of HATCH score in predicting the success rate of sinus rhythm following electrical cardioversion of atrial fibrillation.
|
Kardiol Pol
|
2016
|
0.75
|
|
41
|
Usefulness of HATCH score in the prediction of new-onset atrial fibrillation for Asians.
|
Medicine (Baltimore)
|
2017
|
0.75
|